Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 211Triple Negative Breast Neoplasms 32Inflammatory Breast Neoplasms 21Breast Neoplasms, Male 5Primary Breast Cancer 3Neoplasms 3Carcinoma, Ductal, Breast 3Pathologic Complete Response 2HER2-negative Breast Cancer 2Cardiotoxicity 2Breast Diseases 2Women With Primary Breast Cancer 1Unilateral HER2 Positive Breast Cancer 1Sarcoma 1Resectable HER2-positive Breast Cancer 1Postoperative Complications 1Patient Acceptance of Health Care 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Neutropenia 1Neoplastic Cells, Circulating 1Neoplasm Micrometastasis 1Neoadjuvant Operable Breast Cancer 1Kenny-Caffey syndrome, Type 1 1Hormone Receptor Positive HER-2 Negative Breast Cancer 1Her2-Positive Breast Cancer 1HR-positive,HER2-negative Breast Cancer 1HR+/HER2- Breast Cancer 1HER2-negative Early Breast Cancer 1HER2 Positive Early Breast Cancer 1

Interventions

pegfilgrastim 16Filgrastim 9Docetaxel 6Cyclophosphamide 6pegylated granulocyte colony-stimulating factor 3eflapegrastim 3liposomal amphotericin B 2Doxorubicin 2Moxibustion 1Methotrexate 1Maxy G34 1MYL-1401H 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Epirubicin 1EC regimen 1Cefepime 1Caspofungin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × Epirubicin × Breast × Clear all
NCT00002866 2020-04-01

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Canadian Cancer Trials Group

Phase 1 Completed
50 enrolled
Breast

Breast Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡